We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

154 hedge funds and large institutions have $2.59B invested in Aegerion Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

33% more capital invested

Capital invested by funds: $1.94B → $2.59B (+$648M)

24% more call options, than puts

Call options by funds: $204M | Put options by funds: $165M

6% more funds holding

Funds holding: 145 → 154 (+9)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

Holders
154
Holders Change
+9
Holders Change %
+6.21%
% of All Funds
4.99%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
31
Increased
59
Reduced
59
Closed
20
Calls
$204M
Puts
$165M
Net Calls
+$38.8M
Net Calls Change
+$7.5M

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$60.1M
2
EAM
Eagle Asset Management
Florida
+$53.8M
3
American Century Companies
American Century Companies
Missouri
+$40.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$39.9M
5
Wells Fargo
Wells Fargo
California
+$38.4M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$106M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$70M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$69.1M
4
SM
Sabby Management
Florida
-$28.4M
5
PHS
PFM Health Sciences
California
-$20M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
76
AQR Capital Management
Connecticut
$2.61M +$720K +8,500 +39%
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
$2.55M -$744K -8,781 -23%
ProShare Advisors
78
ProShare Advisors
Maryland
$2.49M +$439K +5,182 +22%
LCG
79
Lisanti Capital Growth
New York
$2.38M +$690K +8,145 +42%
CS
80
Credit Suisse
Switzerland
$2.35M -$641K -7,557 -22%
U
81
UBS
Switzerland
$2.33M -$39.2K -463 -2%
Group One Trading
82
Group One Trading
Illinois
$2.29M -$3.24M -38,223 -59%
California Public Employees Retirement System
83
California Public Employees Retirement System
California
$2.13M +$653K +7,700 +45%
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$1.93M -$85.1K -1,004 -4%
DILH
85
Dai-ichi Life Holdings
Japan
$1.91M +$1.89M +22,278 New
DCM
86
Driehaus Capital Management
Illinois
$1.86M -$10.1M -119,095 -85%
FM
87
Forward Management
California
$1.84M +$447K +5,270 +22%
D.E. Shaw & Co
88
D.E. Shaw & Co
New York
$1.83M -$4.22M -49,735 -70%
SO
89
STRS Ohio
Ohio
$1.83M +$67.8K +800 +4%
AIG
90
American International Group
New York
$1.66M -$7.29K -86 -0.4%
VOYA Investment Management
91
VOYA Investment Management
Georgia
$1.56M – – –
Neuberger Berman Group
92
Neuberger Berman Group
New York
$1.55M +$1.54M +18,126 New
Swiss National Bank
93
Swiss National Bank
Switzerland
$1.52M -$50.9K -600 -3%
DCP
94
DSM Capital Partners
Florida
$1.46M +$465K +5,490 +48%
NTCOC
95
Northern Trust Company of Connecticut
Connecticut
$1.45M -$18.2K -215 -1%
N
96
Nuveen
North Carolina
$1.44M +$1.42M +16,745 New
WT
97
Whittier Trust
California
$1.43M -$770K -9,080 -35%
DekaBank Deutsche Girozentrale
98
DekaBank Deutsche Girozentrale
Germany
$1.38M +$55.1K +650 +4%
Two Sigma Investments
99
Two Sigma Investments
New York
$1.37M -$368K -4,344 -21%
Connor, Clark & Lunn Investment Management (CC&L)
100
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.11M -$161K -1,900 -13%
2 3
4
5 6

AEGR Hedge Fund Activity: Q3 2013 in Review

154 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q3 2013, worth a combined $2.59B — up 33% from $1.94B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new AEGR positions and 20 closed out — a net gain of 11 holders — while 59 added to existing stakes and 59 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $60.1M. The largest seller was Perceptive Advisors, cutting an estimated $106M.

  • 154 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q3 2013, up from 145 in Q2 2013.
  • Funds reported $2.59B of Aegerion Pharmaceuticals stock for Q3 2013, up 33% quarter-over-quarter.
  • 31 funds opened new Aegerion Pharmaceuticals positions in Q3 2013 and 20 closed out, a net change of +11 holders.
  • The largest Aegerion Pharmaceuticals buyer in Q3 2013 was Viking Global Investors, an estimated $60.1M added.
  • The largest Aegerion Pharmaceuticals seller in Q3 2013 was Perceptive Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q3 2013.